New program boosts HIV prevention prescriptions in san francisco clinics

NCT ID NCT03532191

Completed Prevention Sponsor: University of California, San Francisco Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tested a program to help healthcare providers prescribe HIV PrEP (pre-exposure prophylaxis) more effectively. The program included a web-based tool and a coordinator to support doctors. Ten clinics in San Francisco participated. The goal was to see if the program increased the number of PrEP prescriptions written for patients at risk of HIV.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: PrEP Optimization Intervention (PrEP-OI) including a web-based tool and a PrEP Coordinator
What this could lead to: If successful, this program could help more at-risk patients get HIV PrEP, reducing new HIV infections.
What could go wrong: This was a very small study (10 clinics) with no control group, so results may not apply broadly. It focused on provider behavior, not patient outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV/AIDS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

AIDS HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV/AIDS

Contacts and locations

Locations

UCSF Center for AIDS Prevention Studies

San Francisco, California, 94158, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.